Registration Closing Soon for 2nd Digital Exosome Based Therapeutic Development Summit
We are only two weeks away from the much-anticipated 2nd Digital Exosome Based Therapeutic Development Summit (November 11-12). Bringing together industry leaders and newcomers in the field, this is the only industry-dedicated meeting focused on advancing and scaling exosome-based therapeutics into a clinical and commercial reality.
At this unique meeting you’ll be able to experience:
2 Days of Learning | 80+ Expert Industry Attendees | 20 Focused Case Studies | 4+ Dedicated Networking Hours
… and all of this 100% dedicated to the challenges and innovation currently taking place in exosome therapeutics as preparations are underway for the first clinical trials.
Highlights of the 2020 agenda
With 20+ speakers and 2 days of unrivaled in-depth content addressing your most pressing questions, join your peers to discuss:
- Harnessing cell biology to engineer and design clinically effective exosome platforms with Xosomix, Brainstorm Cell Therapeutics & more
- Achieving consistent clinical performance of exosome-based therapies as manufacturing is scaled with Codiak Biosciences & ReNeuron
- Clinical utility of exosome products loaded with gene therapy & siRNA across neuro, cardiovascular & immunological disease with Anjarium Biosciences, Aruna Bio & Harvard Medical School
- Innovation in the applications of exosomes for COVID-19 vaccines with Capricor Therapeutics
This does not cover half the event content… Access the digital event guide here to see the full speaker faculty and session details.
Confirmed Attendees
We have been blown away by the response from the industry. So much so, we wanted to show you just a snippet of the audience we have built!
- Aegle Therapeutics
- Alnylam Pharmaceuticals
- Astellas Pharma Inc
- AstraZeneca
- Boehringer Ingelheim
- Celularity
- Codiak Biosciences
- Direct Biologics
- Evox Therapeutics Ltd.
- Exogenus Therapeutics
- Exonox Biosciences
- Exopharm Ltd
- GenCure
- ILIAS Biologics Inc.
- InnoCan Pharma
- Inserm
- Korea Institute of Science & Technology
- Kourion Therapeutics
- Mantra Bio
- Merck
- NeoBiosis, LLC
- NOVADIP Biosciences S.A.
- The Scripps Research Institute
- Vertex Pharmaceuticals Inc.
- Vesigen Therapeutics
- VivaZome Therapeutics
- VIVEX Biologics
And many more… Get in touch to see all companies and job titles of confirmed attendees.
Don’t miss out! Limited passes remain – register your attendance now.
Contact
General Enquiries & Registration Assistance
Aiden Jordan
Delegate Acquisition Manager
Hanson Wade
(+1) 617 455 4188
info@hansonwade.com
Partnership Opportunities
Adam Mayar
Partnerships Director
Hanson Wade
(+1) 617 455 4188
sponsor@hansonwade.com